Patients with progressive pulmonary fibrosis and systemic autoimmune rheumatic diseases face high mortality risks regardless of specific diagnosis.

Pausing biologic or JAK inhibitor therapy after COVID-19 vaccination does not improve immune response and increases flare risk in arthritis.

Adult patients with axial spondyloarthritis achieved remission and sustained remission over extended follow-up receiving usual care ...

Florida dengue cases have risen following emergency declarations, with Hillsborough County remaining the focal point of the viral outbreak.

HealthDay News — For patients with rheumatoid arthritis (RA), patient-reported outcomes (PROs) generally worsen shortly after tumor necrosis factor inhibitor (TNFi) discontinuation, according to a ...

Increased CD4+ and CD8+ T-cell density in salivary gland tissue is evident in patients with Sjögren syndrome prior to measurable salivary dysfunction.

In patients with rheumatoid arthritis, baseline frailty and prefrailty are linked to a significantly increased risk for incident cancer.

Medical device adverse event summary reports filed in the FDA often contain incomplete problem descriptions, errors, and reporting delays.

A high burden of SDOH is linked to worse respiratory symptoms and reduced exercise capacity after SARS-CoV-2 infection.

Intraoperative low-dose intravenous esketamine reduces acute postoperative pain and the need for rescue analgesics without increasing adverse events.

State public health officials requested high-volume measles tests from the CDC to accelerate case confirmation and limit transmission.

COVID-19 vaccination is linked to decreased in-hospital mortality and shorter hospital stays among patients receiving immunomodulatory therapies.